4-(1H-Imidazol-1-yl)benzonitrile(CAS: 25372-03-6)

4-(1H-Imidazol-1-yl)benzonitrile (CAS: 25372-03-6) must comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous communication. In the European Union, it should adhere to REACH regulations, which require registration, evaluation, authorization, and restriction of chemicals. Additionally, FDA and EPA guidelines apply for any pharmaceutical or environmental concerns. Companies should consult the Material Safety Data Sheet (MSDS) for specific handling and disposal instructions.

Alternatives to 4-(1H-Imidazol-1-yl)benzonitrile (CAS: 25372-03-6) in synthesis include 1H-imidazole derivatives with different substituents, such as 1-(2-cyanoethyl)-1H-imidazole. Commonly used alternative reagents include anilines and nitriles. Researchers should consider the reactivity and availability of these alternatives to optimize the synthesis process.

The market for 4-(1H-Imidazol-1-yl)benzonitrile (CAS: 25372-03-6) is growing due to its use in pharmaceuticals, particularly as a precursor for antiviral drugs. Research trends include exploring its potential in anti-inflammatory and antitumor applications. The demand is expected to increase as novel applications are discovered, driving further studies and industrial adoption.

Waste containing 4-(1H-Imidazol-1-yl)benzonitrile (CAS: 25372-03-6) should be collected in appropriate containers and stored separately. Incineration is a common method for disposal, though professional waste treatment facilities handle such waste to ensure environmental safety. Companies should follow local environmental protection regulations and consult with waste management experts for safe and compliant disposal.